Researchers Use AI to Design Novel Viruses, Highlighting Dual-Use Potential
A team of researchers has shown that artificial intelligence can be used to design entirely new viruses, raising both hopes for medical innovation and concerns about biological security.
The work, published in peer-reviewed literature, demonstrates that generative AI systems can produce functional viral sequences—not merely modified versions of existing pathogens, but novel organisms that had never existed in nature. In their experiments, the researchers created 16 new bacteriophages, which are viruses that infect bacteria rather than humans.
Potential benefits
The researchers focused on bacteriophages because they offer a promising avenue for treating antibiotic-resistant infections. As bacteria evolve to resist existing antibiotics, scientists are exploring whether customized viruses could be engineered to target specific bacterial strains. The AI-designed phages showed functional activity against target bacteria in laboratory settings, suggesting the approach could accelerate phage therapy development.
Security considerations
The study explicitly addresses the dual-use nature of this research. Experts not involved in the work have noted that the techniques demonstrated could, in principle, be adapted to other viral systems. The researchers themselves implemented screening measures during their work and are calling for broader discussions about governance frameworks for AI-generated biological sequences.
This research adds to an ongoing scientific and policy debate about how to balance AI's potential to accelerate beneficial biotechnology with safeguards against intentional misuse. The work underscores ongoing efforts to develop norms and technical controls for life sciences research with dual-use potential.